ICAM1 and neoplasm: For example, EGFR-CAR-T cells significantly inhibit TNBC growth in vitro and in vivo (142), and ICAM-1-specific CAR-T cells effectively reduce tumor growth by targeting ICAM-1-expressing TNBC cells (143).